P2RY12 and cancer: Although these findings suggest a role for P2Y12-R in mediating platelet–cancer cell crosstalk and provide evidence for the use of P2Y12-R antagonists as an additional strategy in chemotherapy, no results from RCTs aimed at assessing their effect on cancer and metastasis are available.